Insights & Analysis
Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.
More articles — Page 32
Page 32 of 51 · 464 articles
Grand Jury Subpoenas in Healthcare Investigations
A guide to document and testimony subpoenas, grand jury secrecy, privilege, and production strategy for physicians facing a federa…
UPIC Site Visits: How to Prepare and What Inspectors Review
An unannounced UPIC site visit can arrive without warning. What inspectors review, how staff interviews work, and why counsel belo…
The Credible Allegation of Fraud Standard in Medicaid Enforcement
A thin, unverified referral can trigger a mandatory Medicaid payment suspension. Here is how states define a credible fraud allega…
UPIC Audits Explained: The Fraud-Focused Medicare Contractor
UPICs investigate suspected Medicare and Medicaid fraud, not payment accuracy. What a UPIC letter means and how its mandate differ…
Medicaid Exclusion and Termination: Collateral Consequences of an Audit
A state Medicaid termination for cause can trigger mandatory cross-state termination and federal OIG exclusion. What physicians sh…
When to Engage a Medicare Audit Attorney
The points in a Medicare audit where legal exposure escalates: extrapolated demands, prepayment review, fraud referrals, and revoc…
Humana Pharmacy Audits: What to Expect and How to Respond
A guide to Humana Pharmacy Solutions audit formats, the documentation requested, common discrepancy findings, and the appeal windo…
MedImpact Audit Findings: How Pharmacies Respond
How MedImpact conducts desk and onsite pharmacy audits, the documentation standards it applies, and how a pharmacy should respond…
Responding to a Civil Investigative Demand (CID)
How a civil investigative demand works under the False Claims Act, what it can compel, and how to negotiate its scope before respo…